Antimicrobial activity of three investigational oral cephalosporins (BK-218, cefdinir, and RU29246) against Legionella (Q44722037)

5 December 2017

Antimicrobial activity of three investigational oral cephalosporins (BK-218, cefdinir, and RU29246) against Legionella (English)

1 reference

https://api.crossref.org/works/10.1016/0732-8893(91)90011-4

29 November 2022

1 reference

2

M. E. Erwin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1802542

29 November 2022

author name string

R. N. Jones

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1802542

29 November 2022

M. S. Barrett

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1802542

29 November 2022

language of work or name

1 reference

1 November 1991

1 reference

full work available at URL

5 December 2017

https://api.elsevier.com/content/article/PII:0732889391900114?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0732-8893(91)90011-4

https://api.elsevier.com/content/article/PII:0732889391900114?httpAccept=text/plain

29 November 2022

1 reference

https://api.crossref.org/works/10.1016/0732-8893(91)90011-4

Diagnostic Microbiology and Infectious Disease

29 November 2022

published in

1 reference

5 December 2017

14

1 reference

5 December 2017

6

1 reference

5 December 2017

519-521

1 reference

Antimicrobial Susceptibility of Intracellular Legionella pneumophila

5 December 2017

1

1 reference

https://api.crossref.org/works/10.1016/0732-8893(91)90011-4

The effect of charcoal on MICs for Legionella

29 November 2022

2

1 reference

https://api.crossref.org/works/10.1016/0732-8893(91)90011-4

Determination of the activity on Legionella of eight macrolides and related agents by comparative testing on three media

29 November 2022

3

1 reference

https://api.crossref.org/works/10.1016/0732-8893(91)90011-4

Uptake of ciprofloxacin by human neutrophils

29 November 2022

4

1 reference

https://api.crossref.org/works/10.1016/0732-8893(91)90011-4

Charcoal-yeast extract agar: primary isolation medium for Legionella pneumophila

29 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/0732-8893(91)90011-4

Legionnaires' disease: description of an epidemic of pneumonia

29 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/0732-8893(91)90011-4

Inactivation of beta-lactam antibiotics by Legionella pneumophila

29 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/0732-8893(91)90011-4

The antimicrobial activity of A-56268 (TE-031) and roxithromycin (RU965) against Legionella using broth microdilution method

29 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/0732-8893(91)90011-4

In vitro antibacterial activity of FK482, a new orally active cephalosporin

29 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/0732-8893(91)90011-4

Comparative in vitro activity and beta-lactamase stability of FK482, a new oral cephalosporin

29 November 2022

13

1 reference

https://api.crossref.org/works/10.1016/0732-8893(91)90011-4

Susceptibility of Legionella pneumophila to ofloxacin in vitro and in experimental Legionella pneumonia in guinea pigs

29 November 2022

15

1 reference

https://api.crossref.org/works/10.1016/0732-8893(91)90011-4

In vitro investigation of BK-218, a new oral and parenteral cephalosporin

29 November 2022

17

1 reference

https://api.crossref.org/works/10.1016/0732-8893(91)90011-4

Inhibition of Legionella pneumophila multiplication within human macrophages by antimicrobial agents

29 November 2022

18

1 reference

https://api.crossref.org/works/10.1016/0732-8893(91)90011-4

29 November 2022

Identifiers

1 reference

5 December 2017

1 reference